ESMO Preceptorship on Prostate Cancer Lugano October 2019

17 - 18 Oct 2019

Lugano, Switzerland

ESMO Preceptorship on Prostate Cancer

Presentations from all ESMO Preceptorship courses are open to all according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The use of these presentations is for personal educational purposes only.

Meeting programme | Next/upcoming meetings

Learning objectives

To learn about fundamentals of epidemology, natural history and diagnosis as contributing factors to heterogeneity in prostate cancer
To understand essentials in the assessment and multidisciplinary treatment of prostate cancer
To learn about advances in treatment and novel targets in prostate cancer

This event has been supported by an unrestricted educational grant from Bayer and Janssen Oncology.

Hide

There are 33 resources available

18 Oct 2019

Participant Clinical Case Discussion: Metastatic prostate cancer with neuroendocrine differentiation

Presenter: U. Bokal, SLO

Session: Session 6 Metastatic disease

Resources:

18 Oct 2019

Participant Clinical Case Discussion: Treatment Sequencing in Prostate Cancer

Presenter: A. S. Spencer, PL

Session: Session 6 Metastatic disease

Resources:

18 Oct 2019

Immunotherapy and other new drug targets (including DNA repair, PSMA-therapy)

Presenter: K. Fizazi, FR

Session: Session 6 Metastatic disease

Resources:

18 Oct 2019

Metastatic CRPC: Current treatment

Presenter: S. Gillessen, CH

Session: Session 6 Metastatic disease

Resources:

18 Oct 2019

Participant Clinical Case Discussion: MO Castration Resistant Prostate Cancer

Presenter: M. Bebek, HR

Session: Session 5 Advanced prostate cancer

Resources:

18 Oct 2019

Participant Clinical Case Discussion: DIC in metastatic Prostate Cancer

Presenter: K. Psianou, GR

Session: Session 5 Advanced prostate cancer

Resources:

18 Oct 2019

Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Presenter: S. Gillessen, CH

Session: Session 5 Advanced prostate cancer

Resources:

18 Oct 2019

M0 CRPC: Prognosis and treatments

Presenter: K. Fizazi, FR

Session: Session 5 Advanced prostate cancer

Resources:

18 Oct 2019

Rising PSA after radical local treatment: Prognosis, indications for local and systemic treatments

Presenter: T. M. de Reijke, NL

Session: Session 5 Advanced prostate cancer

Resources:

17 Oct 2019

Participant Clinical Case Discussion: Olaparib in metastatic castration-resistant prostate cancer with BRCA2 mutation

Presenter: I. Costa, PL

Session: Session 4 Systemic therapy

Resources: